Bomi Italia S.p.A. PRESS RELEASE. A) Approval of the six month interim results to 30 June B) Group corporate restructuring project

Transcription

1 Bomi Italia S.p.A. PRESS RELEASE A) Approval of the six month interim results to 30 June 2017 B) Group corporate restructuring project A) Approval of the six month interim results to 30 June 2017 Consolidated Value of Production was Euro 58,639,564 compared to Euro 46,735,978 at 30 June 2016 Consolidated Gross Operating Margin (EBITDA) was positive for Euro 5,633,863, net of non-recurring and extraordinary items, compared to Euro 3,789,002 at 30 June Consolidated Net Profit of Euro 1,563,264, of which Net Profit attributable to Bomi Group is Euro 965,888, compared to Euro 663,952 at 30 June 2016 of which Net Profit attributable to Bomi Group was Euro 272,732. Consolidated Net Financial Position shows net debt of Euro 17,800,071 Consolidated Net Equity of Euro 19,332,297 Vaprio d Adda, 29 September 2017 Bomi Italia S.p.A. ( Bomi or the Company or the Issuer ), Parent Company of the Bomi Group, a world leader in the biomedical logistics sector and in the management of high technology healthcare products which is listed on the multilateral trading platform of AIM Italia / Alternative Capital Market states that the Board of Directors has today approved the consolidated six month results, prepared in accordance with international accounting principles (IAS/IFRS), for the period to 30 June Giorgio Ruini, the President of the Board of Directors stated: In the first half of 2017 the Bomi Group achieved significant growth in revenues, profitability and net profit due to the dedicated commitment and the challenges undertaken by the entire group to integrate the recent acquisitions of the past two years. We believe, therefore, that we have pursued the right course but there is much that we can still do to steer the group towards significant growth. Main economic data of the Group:

2 / /06/ /06/ vs'16 Value of production ,0% ,0% 25,5% Services costs and others (38.528) -65,7% (31.469) -67,3% 22,4% Personnel Costs (13.100) -22,3% (10.370) -22,2% 26,3% Other operating charges (1.378) -2,4% (1.108) -2,4% 24,4% Gross operating profit (EBITDA) ,6% ,1% 48,7% Amortization, depreciation and writedowns (2.098) -3,6% (1.499) -3,2% 40,0% Extraordinary Income (costs) (478) -0,8% (625) -1,3% -23,5% Net operating profit (EBIT) ,2% ,6% 83,6% Financial Income (costs) (604) -1,0% (623) -1,3% -3,1% Net profit before tax ,2% ,2% 135,3% Taxes (890) -1,5% (379) -0,8% 135,1% Net result ,7% 664 1,4% 135,4% Net result attributable to non-controlling interests 597 1,0% 391 0,8% 52,7% Net result attributable to the Group 966 1,6% 273 0,6% 254,2% Consolidated revenues rose by 25.5% compared with the same period of the previous year. 12% of the increase is attributable to internally generated growth, 8% is due to the positive effect of exchange rates (primarily Euro/Brazilian real) while the remaining 5% is attributable to the inclusion in the consolidation area of the newly acquired companies principally the subsidiary Bomi Logistic Jiangsu, the Chinese company acquired in the second half of The following table shows a breakdown of sales by geographical area, which confirms the trend towards a balancing of the proportion of revenues generated in Euro and those generated in foreign currencies, a trend that should allow the Group to limit the effect of volatility and macroeconomic fluctuations on its results: /000 30/06/2017 % sul tot 30/06/2016 % sul tot 17 vs'16 Italy ,0% ,2% 7,4% Rest of Europe ,0% ,5% -0,8% Brazil ,5% ,4% 36,2% Rest of Latam ,3% ,8% 17,3% Turkey ,6% 378 0,8% 618,0% China ,1% - 0,0% 100,0% Other 301 0,5% 593 1,3% -49,2% Total ,0% ,0% 25,5% The Brazilian company recorded a 14% increase in operating revenues in local currency, which was positively influenced by exchange rate trends on conversion into Euro. European revenues rose by 6.6% compared with the same period of The Turkish subsidiary reported strong growth in revenues. The Consolidated Gross Operating Profit, stated before depreciation, provisions and excluding extraordinary and non-recurring costs, rose by 48.7% in the period to 30 June 2017 compared to the same period of Non-recurring and extraordinary costs amounting to about Euro 47,000 relate to one-off expenses incurred for the transfer of operating headquarters in Italy, a further Euro 287,000 relate to personnel reduction incentives primarily in the Brazilian subsidiary and about Euro 179,000 refer to various other contingent liabilities.

3 There was a clear improvement in the Consolidated Operating Profit compared to the same period of 2016 due to the dedicated commitment made by the entire Group to optimise costs and consolidate the companies acquired between 2015 and 2016 with the objective of achieving the expected synergies in order to improve profitability. The most significant contributor to improved profitability in the first semester of 2017 came from the parent company and its Italian subsidiaries due to initiatives to improve the efficiency of its fleet, from the Brazilian subsidiary which continues on its growth path both in terms of revenues and profitability, and from the newly acquired subsidiary in China. Overall, the entire Group is continuing to focus on cost rationalisation and margin improvement, which is also generating positive results in those Group companies previously in start-up phase such as the subsidiaries in Colombia, Chile, Peru and Turkey, which are expected to make an increasing positive contribution. Net Profit rose by 135% and the Net Profit attributable to the Group rose by 254% compared to the first half of This significant increase is attributable in particular to the improvement in several group companies and to a consequent improvement in the balancing of corporate development and support costs of existing shareholdings, between the parent company and the subsidiary companies. The following chart illustrates the composition of the Net Financial Position (NFP) at 30 June 2017: The change in the Net Financial Position (NFP) at 30 June 2017 should also be noited:

4 The change in the NFP is largely due to investments made in the first half of 2017 including: Euro 3.47 million, regarding operational investments to set up and support operational headquarters, primarily relating to air-conditioning plant, storage racking/shelving, vehicles and investments in Information Tecnology; Euro 1.84 million for non-operational investments such as the entry into the Mexican market and the purchase of the minority interests in G.Carrai & C. S.r.l., Biocarrier Colombia SAS, Ritmo Holding BV, which at the level of the consolidated financial statements for the first half of 2017 generated a negative difference in equity, since in accordance with IFRS 3 - the goodwill generated by the acquisition of a minority interest must be recognised as a reduction in equity. Major events prior to 30 June 2017 It should be noted that on 15 March 2017 the Bomi Group made a direct entry into the Mexican market through the formation of a newco, called Handling Healthcare SA de CV (Bomi Mexico), arising from the implementation of a Joint Venture agreement with a local partner and, subsequently, on 25 May 2017, the Group, through its subsidiary Bomi Mexico, signed a binding agreement for the acquisition of 100% of the share capital of Espadist S.A. de C.V, a Mexican company operating in the Healthcare logistics sector, for a consideration of about Euro 700,000. Espadist has 20 years of experience in biomedical logistics, both in warehouse management and in transport and benefits from a multinational client list in the sectors of medical devices, in vitro diagnostics and pharmaceuticals. Neither of the newly acquired Mexican subsidiaries were included in the consolidation area at 30 June 2017 as they were not material additions at that date. Major events after 30 June 2017 It should be noted that on 30 July 2017 the Bomi Group announced that it had signed a binding agreement to acquire the minority shareholding, equal to 45% of the share capital of its Brazilian subsidiary Biomedical Distribution Mercosur Ltda, which is expected to be completed by 31 January It should therefore be reported that the results for the period to 30 June 2017 do not include any effects of synergies arising from that transaction. BDO S.p.A., in its capacity as legally appointed independent auditor, has expressed its positive opinion on the abbreviated consolidated interim accounts to 30 June 2017.

5 The Consolidated Interim Financial Statements to 30 June 2017 will be available in the Investor Relations, Financial Documents section of the website in accordance with the terms and conditions established by the AIM Italia Issuers Regulations. B) Group corporate restructuring project The Board of Directors of Bomi has today also approved a comprehensive project to reorganise the Group structure, which will be implemented through the merger by incorporation in G. Carrai & C. S.r.l. ( Carrai ) of the companies Chasqui S.r.l. ( Chasqui ), Berga S.r.l. ( Berga ) and Logik Trans S.r.l. ( Logik Trans ), all of which companies are directly or indirectly controlled by the Issuer. The administrative bodies (i) of the incorporating entity Carrai, over which the Issuer directly has full control, as well as (ii) of the the company to be incorporated, Logik Trans, also fully controlled by the Issuer, (iii) of the the company to be incorporated, Chasqui, fully controlled by the Issuer through Bodi S.r.l. and (iv) of the the company to be incorporated, Berga, 80% of whose share capital is controlled by the Issuer (without prejudice to the exercise of the option to acquire the outstanding capital by the date stipulated in the merger contract), will, in the short term, meet to approve the merger proposal in accordance with article 2501-ter of the Italian Civil Code. The aforementioned merger transaction which is categorized as a so-called simplified merger (pursuant to and in accordance with article 2505 of the Italian Civil Code) forms part of the wider corporate reorganisation project of the Group, with the aim of simplifying its structure and consequently reducing costs, and in so doing to optimise the value of the operating, administrative and management synergies of the various entities operating in similar, related activities. The incorporating entity, Carrai carries out activities of logistics, warehouse and transport management (particularly with regard to the markets for medical and pharmaceutical equipment and home care delivery), while the companies to be incorporated; Chasqui, Berga and Logik Trans are active in the sectors of warehouse management and biomedical product transportation, covering in particular domestic delivery, controlled temperature delivery and hazardous materials transportation. The proposed operation, therefore, is put forward as a natural evolution of the Group s rationalisation strategy with the aim of improving productivity, efficiency and profitability through the reunification, under the incorporating entity, of the activities performed by the incorporated companies, in expectation of the operational homogeneity of the said entities, leading to consequently greater efficiencies and synergies in operational, commercial and productive processes. Given that the equity interests in the companies involved in the merger as well as the more general characteristics of the transaction that do not change the capital or economic profile of the Group, it is reasonably expected that the operation may completed by the end of the current financial year. Bomi Italia S.p.A. is the Parent Company of Bomi Group, a world leader in the biomedical logistics sector and in the management of high technology healthcare products. It was one of the first companies to receive the Elite certificate issued by Borsa Italiana.

6 Bomi Group s activities are concentrated in the integrated logistics sector and offer a wide range of logistics services in outsourcing to companies operating in the healthcare sector, managing distribution of medical equipment, pharmaceuticals, in-vitro diagnostic equipment, reagents and implant products. Bomi Group s portfolio of about 100 clients includes some of the world s top healthcare companies (such as the leading pharmaceutical companies and producers of healthcare devices) as well as small and medium sized companies operating at a global level in the biomedical, diagnostics and biotech industries. Bomi Group currently has about 1,080 employees and operates through subsidiary companies and significant investments in Europe, South America, China and the United States and its services are also provided, through strategic alliances with local partners. ISIN Ordinary Share Code: IT Ordinary Share Ticker: BOMI ISIN Convertible Bond Code: IT Convertible Bond Ticker: BOMI20 For further information. Bomi Italia S.p.A. Intesa Sanpaolo S.p.A. Investor Relator Nominated Adviser tel: tel: : e.mail: investorrelator@bomigroup.com e.mail: stefano.taioli@popvi.it

7 ALLEGATI Consolidation Financial Statement Bomi Group Reclassified Income Statement 30/06/ /06/ vs'16 Value of production ,5% Services costs and others ( ) ( ) 22,4% Personnel Costs ( ) ( ) 26,3% Other operating charges ( ) ( ) 24,4% Gross operating profit (EBITDA) ,7% Amortization, depreciation and writedowns ( ) ( ) 40,0% Extraordinary Income (costs) ( ) ( ) -23,5% Net operating profit (EBIT) ,6% Financial Income (costs) ( ) ( ) -3,1% Net profit before tax ,3% Taxes ( ) ( ) 135,1% Net result ,4% Net result attributable to non-controlling interests ,7% Net result attributable to the Group ,2%

8 Consolidation Financial Statement Bomi Group Reclassified Balance Sheet 30/06/ /12/2016 Change Net Intangible Assests ( ) Net Tangible Assests Long-term investments Other receivables falling due after one year Total Intangibles, Tangible assets and Long-term investments Inventories (28.512) Trade accounts receivable Other receivables Accrued income and prepaid axpenses Total Short-Term assets Accounts payable to suppliers: Payments received on account - Taxes payable and social security contributions ( ) Other liabilities Accrued expenses and deferred income ( ) Total short term liabilities Net Working Capital Reserve for employee termination indemnity Taxes payable and social security contributions falling due after one year Other liabilities falling due after one year Total long term liabilities Invested Capital Shareholders' Equity ( ) ( ) ( ) Net Financial Position falling due after one year ( ) ( ) ( ) Net Financial Position falling due within one year Equity and Net Financial Position ( ) ( ) ( )